Search Within

Population Sciences Research Program

  1. "Elsevier Science, Inc."
  2. "Value in Health"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (2)
Groups
  1. Epidemiology and Biostatistics (6)
  2. Health Outcomes Research Group (5)
  3. Department of Medicine (4)
  4. Solid Tumor Oncology Division (4)
  5. Behavioral Sciences Service (3)
  6. Psychiatry and Behavioral Sciences, Department of (3)

More Groups

People
  1. Peter Bach (5)
  2. Thomas Atkinson (3)
  3. Allison Lipitz Snyderman (2)
  4. Anna Kaltenboeck (2)
  5. Deborah Schrag (2)
  6. Ethan Basch (2)

More People

Years
  1. 2019 (3)
  2. 2018 (2)
  3. 2017 (3)
  4. 2010 (1)
  5. 2006 (1)
  6. 2005 (1)
Publications
  1. Value in Health (11)
Publishers
  1. Elsevier Science, Inc. (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How do new oncology value assessment frameworks compare to the QALY?
    Meeting Abstract

    Russell, J.; Briggs, A.; Elkin, E. B.; Bach, P. B.
    Value in Health (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Perceptions of response burden associated with completion of patient-reported outcome assessments in oncology
    Journal Article

    Atkinson, T. M.; Schwartz, C. E.; Goldstein, L.; Garcia, I.; Storfer, D. F.; Li, Y.; Zhang, J.; Bochner, B. H.; Rapkin, B. D.
    Value in Health (2019)

    Fulltext@MSK | Save
  • Initial development and content validation of a health-related symptom index for persons either treated or monitored fortreated or monitored for anal high-grade squamous intraepithelial lesions
    Journal Article

    Burkhalter, J. E.; Atkinson, T. M.; Berry-Lawhorn, J.; Goldstone, S.; Einstein, M. H.; Wilkin, T. J.; Lee, J.; Cella, D.; Palefsky, J. M.; ANCHOR HRQOL Implementation Group
    Value in Health (2018)

    Fulltext@MSK | Save
  • Estimating the health state utility of patients with HER2-gBCRA+ metastatic breast cancer treated with olaparib or chemotherapy via a mapping analysis of EORTC QLQ-C30 data collected in the OlympiAD clinical trial
    Meeting Abstract

    Robson, M.; Hettle, R.; Degboe, A.; Saunders, O.; Cain, T.; Kilvert, H.; Johnson, H.
    Value in Health (2018)

    Fulltext@MSK | Save
  • But will they trade health? Developing an economic value framework for oncology
    Meeting Abstract

    Briggs, A.; Baba, C.; Lipitz-Snyderman, A.; Kaltenboeck, A.; Mcintosh, E.; Bach, P. B.
    Value in Health (2017)

    Fulltext@MSK | Save
  • Identifying attributes of cancer treatments: What do stakeholders consider important?
    Meeting Abstract

    Baba, C.; Briggs, A.; McIntosh, E.; Lipitz-Snyderman, A.; Kaltenboeck, A.; Bach, P. B.
    Value in Health (2017)

    Fulltext@MSK | Save
  • Delays in clinical trial data release across oncology
    Meeting Abstract

    Qunaj, L.; Jain, R. H.; Atoria, C. L.; Miller, J. E.; Bach, P. B.
    Value in Health (2017)

    Fulltext@MSK | Save
  • Development of the patient-reported version of the common terminology criteria for adverse events (pro-ctcae)
    Meeting Abstract

    Basch, E.; Reeve, B.; Cleeland, C.; Sloan, J.; Mendoza, T.; Abernethy, A.; Bruner, D.; Hay, J.; Atkinson, T.; Sit, L.; more...
    Value in Health (2010)

    Fulltext@MSK | Save
  • Online reporting of toxicity symptoms by lung cancer patients during chemotherapy
    Meeting Abstract

    Basch, E.; Barz, A.; Kris, M.; Culkin, A.; Schrag, D.
    Value in Health (2006)

    Fulltext@MSK | Save